FANH vs. GOCO, RDZN, EHTH, ZBAO, SLQT, OPAD, FSP, CIO, MITT, and NWFL
Should you be buying Fanhua stock or one of its competitors? The main competitors of Fanhua include GoHealth (GOCO), Roadzen (RDZN), eHealth (EHTH), Zhibao Technology (ZBAO), SelectQuote (SLQT), Offerpad Solutions (OPAD), Franklin Street Properties (FSP), City Office REIT (CIO), AG Mortgage Investment Trust (MITT), and Norwood Financial (NWFL). These companies are all part of the "finance" sector.
GoHealth (NASDAQ:GOCO) and Fanhua (NASDAQ:FANH) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, community ranking, profitability, earnings and risk.
Fanhua received 194 more outperform votes than GoHealth when rated by MarketBeat users. Likewise, 54.31% of users gave Fanhua an outperform vote while only 53.42% of users gave GoHealth an outperform vote.
Fanhua has a net margin of 8.67% compared to Fanhua's net margin of -8.59%. GoHealth's return on equity of 12.11% beat Fanhua's return on equity.
Fanhua has lower revenue, but higher earnings than GoHealth. GoHealth is trading at a lower price-to-earnings ratio than Fanhua, indicating that it is currently the more affordable of the two stocks.
24.2% of GoHealth shares are owned by institutional investors. Comparatively, 26.7% of Fanhua shares are owned by institutional investors. 52.0% of GoHealth shares are owned by insiders. Comparatively, 25.6% of Fanhua shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
In the previous week, Fanhua had 2 more articles in the media than GoHealth. MarketBeat recorded 2 mentions for Fanhua and 0 mentions for GoHealth. GoHealth's average media sentiment score of 0.25 beat Fanhua's score of 0.00 indicating that Fanhua is being referred to more favorably in the news media.
GoHealth presently has a consensus target price of $13.00, suggesting a potential upside of 52.40%. Given Fanhua's higher probable upside, analysts plainly believe GoHealth is more favorable than Fanhua.
Summary
Fanhua beats GoHealth on 12 of the 15 factors compared between the two stocks.
Get Fanhua News Delivered to You Automatically
Sign up to receive the latest news and ratings for FANH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FANH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
